Page last updated: 2024-11-03

riluzole and Glioma

riluzole has been researched along with Glioma in 6 studies

Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.

Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)

Research Excerpts

ExcerptRelevanceReference
"Riluzole and memantine can be safely and effectively delivered intracranially via polymer in rat glioma models."7.80Efficacy of local polymer-based and systemic delivery of the anti-glutamatergic agents riluzole and memantine in rat glioma models. ( Blakeley, J; Brem, H; Gincel, D; Pardo, AC; Rothstein, JD; Tyler, B; Weaver, KD; Yohay, K, 2014)
" This study examined the effect of riluzole on [Ca2+]i in IMR32 neuroblastoma cells using fura-2 as a Ca2+ probe."7.71Effect of the neuroprotective agent riluzole on intracellular Ca2+ levels in IMR32 neuroblastoma cells. ( Chang, CH; Chen, WC; Chow, CK; Jan, CR; Law, YP; Lee, KC; Lu, T; Su, W; Tang, KY; Wang, JL, 2001)
"In the present study, we investigated the effects of mGluR1 inhibition in human glioma U87 cells using specific targeted small interfering RNA (siRNA) or selective antagonists Riluzole and BAY36-7620."3.81Anti-cancer effect of metabotropic glutamate receptor 1 inhibition in human glioma U87 cells: involvement of PI3K/Akt/mTOR pathway. ( Li, HY; Liao, YW; Liu, Q; Sang, SS; Su, J; Wang, XY; Yuan, XR; Zhang, C; Zhao, ZJ, 2015)
"Riluzole and memantine can be safely and effectively delivered intracranially via polymer in rat glioma models."3.80Efficacy of local polymer-based and systemic delivery of the anti-glutamatergic agents riluzole and memantine in rat glioma models. ( Blakeley, J; Brem, H; Gincel, D; Pardo, AC; Rothstein, JD; Tyler, B; Weaver, KD; Yohay, K, 2014)
" Finally, we investigated its effects on pilocarpine-induced seizures in rats."3.78Characterizing the effects of Eugenol on neuronal ionic currents and hyperexcitability. ( Chow, JC; Huang, CW; Tsai, JJ; Wu, SN, 2012)
" This study examined the effect of riluzole on [Ca2+]i in IMR32 neuroblastoma cells using fura-2 as a Ca2+ probe."3.71Effect of the neuroprotective agent riluzole on intracellular Ca2+ levels in IMR32 neuroblastoma cells. ( Chang, CH; Chen, WC; Chow, CK; Jan, CR; Law, YP; Lee, KC; Lu, T; Su, W; Tang, KY; Wang, JL, 2001)
"Riluzole is a drug approved for the treatment of amyotrophic lateral sclerosis (ALS) and may be effective for the treatment of other neurodegenerative and neuropsychiatric disorders."1.39Riluzole increases glutamate uptake by cultured C6 astroglial cells. ( Bobermin, LD; Dall'Igna, OP; Quincozes-Santos, A; Souza, DO, 2013)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's5 (83.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dall'Igna, OP1
Bobermin, LD1
Souza, DO1
Quincozes-Santos, A1
Yohay, K1
Tyler, B1
Weaver, KD1
Pardo, AC1
Gincel, D1
Blakeley, J1
Brem, H1
Rothstein, JD1
Zhang, C1
Yuan, XR1
Li, HY1
Zhao, ZJ1
Liao, YW1
Wang, XY1
Su, J1
Sang, SS1
Liu, Q1
Tsuchioka, M1
Hisaoka, K1
Yano, R1
Shibasaki, C1
Kajiatani, N1
Takebayashi, M1
Huang, CW1
Chow, JC1
Tsai, JJ1
Wu, SN1
Wang, JL1
Lee, KC1
Tang, KY1
Lu, T1
Chang, CH1
Chow, CK1
Chen, WC1
Su, W1
Law, YP1
Jan, CR1

Other Studies

6 other studies available for riluzole and Glioma

ArticleYear
Riluzole increases glutamate uptake by cultured C6 astroglial cells.
    International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience, 2013, Volume: 31, Issue:7

    Topics: Analysis of Variance; Animals; Astrocytes; Cell Line, Tumor; Dose-Response Relationship, Drug; Excit

2013
Efficacy of local polymer-based and systemic delivery of the anti-glutamatergic agents riluzole and memantine in rat glioma models.
    Journal of neurosurgery, 2014, Volume: 120, Issue:4

    Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Disease Models, Animal; Drug Delivery Systems; Excitator

2014
Anti-cancer effect of metabotropic glutamate receptor 1 inhibition in human glioma U87 cells: involvement of PI3K/Akt/mTOR pathway.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2015, Volume: 35, Issue:2

    Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Movement; Glioma

2015
Riluzole-induced glial cell line-derived neurotrophic factor production is regulated through fibroblast growth factor receptor signaling in rat C6 glioma cells.
    Brain research, 2011, Apr-12, Volume: 1384

    Topics: Animals; Cell Line, Tumor; CREB-Binding Protein; Dose-Response Relationship, Drug; Drug Interactions

2011
Characterizing the effects of Eugenol on neuronal ionic currents and hyperexcitability.
    Psychopharmacology, 2012, Volume: 221, Issue:4

    Topics: Action Potentials; Animals; Calcium Channels, L-Type; Cell Line, Tumor; Delayed Rectifier Potassium

2012
Effect of the neuroprotective agent riluzole on intracellular Ca2+ levels in IMR32 neuroblastoma cells.
    Archives of toxicology, 2001, Volume: 75, Issue:4

    Topics: Animals; Brefeldin A; Calcium; Calcium Channel Blockers; Carbonyl Cyanide m-Chlorophenyl Hydrazone;

2001